Advertisement

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
      ankle–brachial index

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • SIGN (Scottish Intercollegiate Guidelines Network)
        Risk estimation and the prevention of cardiovascular disease.
        A Natl Clin Guidel. 2007; (Report No. 97)
        • World Health Organization
        Joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases.
        2002 (Report No. 916)
      1. Last J.M. A dictionary of epidemiology. 4th ed. Oxford University Press, New York2001
        • Ferket B.S.
        • Colkesen E.B.
        • Visser J.J.
        • Spronk S.
        • Kraaijenhagen R.A.
        • Steyerberg E.W.
        • et al.
        Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?.
        Arch Intern Med. 2010; 170: 27-40
        • Kotseva K.
        • Wood D.
        • De Backer G.
        • De Bacquer D.
        • Pyorala K.
        • Keil U.
        Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
        Lancet. 2009; 373: 929-940
        • O’Kelly S.
        • Ryden L.
        The political power of heart doctors: with the European Heart Health Charter towards a European policy on cardiovascular disease.
        Eur J Cardiovasc Prev Rehabil. 2009; 16: S58-S60
        • Woolf S.H.
        • Dickey L.L.
        Differing perspectives on preventive care guidelines: a new look at the mammography controversy.
        Am J Prev Med. 1999; 17: 260-268
        • Grol R.
        • Dalhuijsen J.
        • Thomas S.
        • Veld C.
        • Rutten G.
        • Mokkink H.
        Attributes of clinical guidelines that influence use of guidelines in general practice: observational study.
        BMJ. 1998; 317: 858-861
        • Guyatt G.H.
        • Oxman A.D.
        • Vist G.E.
        • Kunz R.
        • Falck-Ytter Y.
        • Alonso-Coello P.
        • et al.
        GRADE: an emerging consensus on rating quality of evidence strength of recommendations.
        BMJ. 2008; 336: 924-926
        • Guyatt G.H.
        • Oxman A.D.
        • Kunz R.
        • Vist G.E.
        • Falck-Ytter Y.
        • Schunemann H.J.
        What is ‘quality of evidence’ and why is it important to clinicians?.
        BMJ. 2008; 336: 995-998
        • Schunemann H.J.
        • Oxman A.D.
        • Brozek J.
        • Glasziou P.
        • Jaeschke R.
        • Vist G.E.
        • et al.
        Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.
        BMJ. 2008; 336: 1106-1110
      2. World Health Organization, Regional Office for Europe. The prevention and control of major cardiovascular diseases. Rep a Conf. 1973. Report No. Euro 8214.

        • Mirzaei M.
        • Truswell A.S.
        • Taylor R.
        • Leeder S.R.
        Coronary heart disease epidemics: not all the same.
        Heart. 2009; 95: 740-746
        • European Heart Network
        European cardiovascular disease statistics.
        2008 ([edition])
        • Levi F.
        • Chatenoud L.
        • Bertuccio P.
        • Lucchini F.
        • Negri E.
        • La Vecchia C.
        Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update.
        Eur J Cardiovasc Prev Rehabil. 2009; 16: 333-350
        • Tunstall-Pedoe H.
        MONICA monograph and multimedia sourcebook.
        (World Health Organization), 2003
        • Ford E.S.
        • Capewell S.
        Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates.
        J Am Coll Cardiol. 2007; 50: 2128-2132
        • Vander Stichele C.
        • De Bacquer D.
        • De Henauw S.
        • Vannoote P.
        • Gevaert S.
        • Populier N.
        • et al.
        Is the decline in coronary attack rates leveling off in Flanders?.
        Eur J Cardiovasc Prev Rehabil. 2008; 15: S1-S31
        • Rose G.
        Sick individuals and sick populations.
        Int J Epidemiol. 1985; 14: 32-38
        • Manuel D.G.
        • Lim J.
        • Tanuseputro P.
        • Anderson G.M.
        • Alter D.A.
        • Laupacis A.
        • et al.
        Revisiting Rose: strategies for reducing coronary heart disease.
        BMJ. 2006; 332: 659-662
        • Forsen T.
        • Eriksson J.G.
        • Tuomilehto J.
        • Osmond C.
        • Barker D.J.
        Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study.
        BMJ. 1999; 319: 1403-1407
        • Painter R.C.
        • de Rooij S.R.
        • Bossuyt P.M.
        • Simmers T.A.
        • Osmond C.
        • Barker D.J.
        • et al.
        Early onset of coronary artery disease after prenatal exposure to the Dutch famine.
        Am J Clin Nutr. 2006; 84 (quiz 466–327): 322-327
        • Vos L.E.
        • Oren A.
        • Uiterwaal C.
        • Gorissen W.H.
        • Grobbee D.E.
        • Bots M.L.
        Adolescent blood pressure and blood pressure tracking into young adulthood are related to subclinical atherosclerosis: the Atherosclerosis Risk in Young Adults (ARYA) study.
        Am J Hypertens. 2003; 16: 549-555
        • Bejan-Angoulvant T.
        • Saadatian-Elahi M.
        • Wright J.M.
        • Schron E.B.
        • Lindholm L.H.
        • Fagard R.
        • et al.
        Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials.
        J Hypertens. 2010; 28: 1366-1372
        • Doolan D.M.
        • Froelicher E.S.
        Smoking cessation interventions and older adults.
        Prog Cardiovasc Nurs. 2008; 23: 119-127
        • Sackett D.L.
        Evidence-based medicine and treatment choices.
        Lancet. 1997; 349 (author reply 572–573): 570
        • McGovern P.G.
        • Jacobs Jr., D.R.
        • Shahar E.
        • Arnett D.K.
        • Folsom A.R.
        • Blackburn H.
        • et al.
        Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey.
        Circulation. 2001; 104: 19-24
        • Fichtenberg C.M.
        • Glantz S.A.
        Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.
        N Engl J Med. 2000; 343: 1772-1777
        • Ford E.S.
        • Ajani U.A.
        • Croft J.B.
        • Critchley J.A.
        • Labarthe D.R.
        • Kottke T.E.
        • et al.
        Explaining the decrease in U.S. deaths from coronary disease, 1980–2000.
        N Engl J Med. 2007; 356: 2388-2398
        • Capewell S.
        • O'Flaherty M.
        Rapid mortality falls after risk-factor changes in populations.
        Lancet. 2011; 378: 752-753
        • Di Chiara A.
        • Vanuzzo D.
        Does surveillance impact on cardiovascular prevention?.
        Eur Heart J. 2009; 30: 1027-1029
        • National Institute for Health and Clinical Excellence
        Prevention of cardiovascular disease: Costing report.
        Nice Public Health Guidance. 2010; 25
        • Kotseva K.
        • Wood D.
        • De Backer G.
        • De Bacquer D.
        • Pyorala K.
        • Keil U.
        EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
        Eur J Cardiovasc Prev Rehabil. 2009; 16: 121-137
        • Kotseva K.
        • Wood D.
        • De Backer G.
        • De Bacquer D.
        • Pyorala K.
        • Reiner Z.
        • et al.
        EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
        Eur J Cardiovasc Prev Rehabil. 2010; 17: 530-540
        • Wood D.A.
        • Kotseva K.
        • Connolly S.
        • Jennings C.
        • Mead A.
        • Jones J.
        • et al.
        Nurse-coordinated multidisciplinary, familybased cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.
        Lancet. 2008; 371: 1999-2012
        • Mosca L.
        • Banka C.L.
        • Benjamin E.J.
        • Berra K.
        • Bushnell C.
        • Dolor R.J.
        • et al.
        Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.
        Circulation. 2007; 115: 1481-1501
        • Graham I.
        • Atar D.
        • Borch-Johnsen K.
        • Boysen G.
        • Burell G.
        • Cifkova R.
        • et al.
        European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
        Eur J Cardiovasc Prev Rehabil. 2007; 14: S1-113
        • Pyorala K.
        • De Backer G.
        • Graham I.
        • Poole-Wilson P.
        • Wood D.
        Prevention of coronary heart disease in clinical practice. Recommendations of the task force of the European society of cardiology, European atherosclerosis society and European society of hypertension.
        Eur Heart J. 1994; 15: 1300-1331
        • EUROASPIRE II Study Group
        Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Heart Survey Programme.
        Eur Heart J. 2001; 22: 554-572
        • Wood D.
        • De Backer G.
        • Faergeman O.
        • Graham I.
        • Mancia G.
        • Pyorala K.
        Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of European and other societies on coronary prevention.
        Atherosclerosis. 1998; 140: 199-270
        • Anderson K.
        • Odell P.
        • Wilson P.
        • Kannel W.B.
        Cardiovascular disease risk profiles.
        Am Heart J. 1991; 121: 293-298
        • Reiner Z.
        • Catapano A.L.
        • De Backer G.
        • Graham I.
        • Taskinen M.R.
        • Wiklund O.
        • et al.
        ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS).
        Eur Heart J. 2011; 32: 1769-1818
        • Marmot M.
        Sustainable development and the social gradient in coronary heart disease.
        Eur Heart J. 2001; 22: 740-750
        • De Backer G.
        • Ambrosioni E.
        • Borch-Johnsen K.
        • Brotons C.
        • Cifkova R.
        • Dallongeville J.
        • et al.
        European guidelines on cardiovascular disease prevention in clinical practice: third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
        Eur J Cardiovasc Prev Rehabil. 2003; 10: S1-S10
        • Conroy R.M.
        • Pyorala K.
        • Fitzgerald A.P.
        • Sans S.
        • Menotti A.
        • De Backer G.
        • et al.
        Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
        Eur Heart J. 2003; 24: 987-1003
        • Aktas M.K.
        • Ozduran V.
        • Pothier C.E.
        • Lang R.
        • Lauer M.S.
        Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program.
        JAMA. 2004; 292: 1462-1468
        • Vartiainen E.
        • Jousilahti P.
        • Alfthan G.
        • Sundvall J.
        • Pietinen P.
        • Puska P.
        Cardiovascular risk factor changes in Finland, 1972–1997.
        Int J Epidemiol. 2000; 29: 49-56
        • Cooney M.T.
        • Dudina A.
        • De Bacquer D.
        • Fitzgerald A.
        • Conroy R.
        • Sans S.
        • et al.
        How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators.
        Eur J Cardiovasc Prev Rehabil. 2009; 16: 304-314
        • Cooney M.T.
        • Dudina A.
        • De Bacquer D.
        • Wilhelmsen L.
        • Sans S.
        • Menotti A.
        • et al.
        HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk.
        Atherosclerosis. 2009; 206: 611-616
        • Cooney M.
        • Dudina A.
        • Bacquer D.D.
        • Fitzgerald A.
        • Conroy R.
        • Sans S.
        • et al.
        How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators.
        Eur J Cardiovasc Prev Rehabil. 2009; 16: 304-314
        • Cooney M.T.
        • Dudina A.
        • De Bacquer D.
        • Wilhelmsen L.
        • Sans S.
        • Menotti A.
        • De Backer G.
        • Jousilahti P.
        • Keil U.
        • Thomsen T.
        • Whincup P.
        • Graham I.M.
        HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk.
        Atherosclerosis. 2009; 206: 611-616
        • Di Angelantonio E.
        • Sarwar N.
        • Perry P.
        • Kaptoge S.
        • Ray K.K.
        • Thompson A.
        • et al.
        Major lipids, apolipoproteins, and risk of vascular disease.
        JAMA. 2009; 302: 1993-2000
        • Ridker P.M.
        Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?.
        Clin Chem. 2008; 54: 11-13
        • Abdel-Maksoud M.F.
        • Hokanson J.E.
        The complex role of triglycerides in cardiovascular disease.
        Semin Vasc Med. 2002; 2: 325-333
        • Sarwar N.
        • Danesh J.
        • Eiriksdottir G.
        • Sigurdsson G.
        • Wareham N.
        • Bingham S.
        • et al.
        Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.
        Circulation. 2007; 115: 450-458
        • Cooney M.T.
        • Vartiainen E.
        • Laatikainen T.
        • Juolevi A.
        • Dudina A.
        • Graham I.M.
        Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women.
        Am Heart J. 2010; 159 (e613): 612-619
        • Shaper A.G.
        • Wannamethee G.
        • Macfarlane P.W.
        • Walker M.
        Heart rate ischaemic heart disease sudden cardiac death in middle-aged British men.
        Br Heart J. 1993; 70: 49-55
        • Jouven X.
        • Empana J.P.
        • Escolano S.
        • Buyck J.F.
        • Tafflet M.
        • Desnos M.
        • et al.
        Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men.
        Am J Cardiol. 2009; 103: 279-283
        • Nauman J.
        • Janszky I.
        • Vatten L.J.
        • Wisloff U.
        Temporal changes in resting heart rate and deaths from ischemic heart disease.
        JAMA. 2011; 306: 2579-2587
        • Fox K.
        • Ford I.
        • Steg P.G.
        • Tendera M.
        • Robertson M.
        • Ferrari R.
        Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.
        Lancet. 2008; 372: 817-821
        • Diaz A.
        • Bourassa M.G.
        • Guertin M.C.
        • Tardif J.C.
        Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
        Eur Heart J. 2005; 26: 967-974
        • Freemantle N.
        • Cleland J.
        • Young P.
        • Mason J.
        • Harrison J.
        Beta Blockade after myocardial infarction: systematic review and meta regression analysis.
        BMJ. 1999; 318: 1730-1737
        • Brophy J.M.
        • Joseph L.
        • Rouleau J.L.
        Beta-blockers in congestive heart failure. A Bayesian meta-analysis.
        Ann Intern Med. 2001; 134: 550-560
        • Fox K.
        • Ford I.
        • Steg P.G.
        • Tendera M.
        • Ferrari R.
        Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
        Lancet. 2008; 372: 807-816
        • Swedberg K.
        • Komajda M.
        • Bohm M.
        • Borer J.S.
        • Ford I.
        • Dubost-Brama A.
        • et al.
        Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebocontrolled study.
        Lancet. 2010; 376: 875-885
        • Wilson P.
        • Pencina M.
        • Jacques P.
        • Selhub J.
        • D’Agostino R.
        • O’Donnell C.
        C-reactive protein reclassification of cardiovascular risk in the Framingham Heart Study.
        Circ Cardiovasc Qual Outcomes. 2008; 1: 92-97
        • Cooney M.T.
        • Vartiainen E.
        • Laatikainen T.
        • DeBacquer D.
        • McGorrian C.M.
        • Dudina A.
        • et al.
        Cardiovascular risk age: Concepts and practicalities.
        Heart. 2012; 98: 941-946
        • Cuende J.I.
        • Cuende N.
        • Calaveras-Lagartos J.
        How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation.
        Eur Heart J. 2010; 31: 2351-2358
        • World Health Organization
        Global health observatory data repository.
        • Catapano A.L.
        • Reiner Z.
        • De Backer G.
        • Graham I.
        • Taskinen M.R.
        • Wiklund O.
        • et al.
        ESC/EAS guidelines for the management of dyslipidaemias. The task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS).
        Atherosclerosis. 2011; 217: 1-44
        • Botkin J.R.
        Informed consent for genetic research.
        Curr Protoc Hum Genet. 2010; ([Chapter 1]:Unit 1 16)
        • Paynter N.P.
        • Chasman D.I.
        • Pare G.
        • Buring J.E.
        • Cook N.R.
        • Miletich J.P.
        • et al.
        Association between a literature-based genetic risk score and cardiovascular events in women.
        JAMA. 2010; 303: 631-637
        • Williams R.R.
        • Hunt S.C.
        • Heiss G.
        • Province M.A.
        • Bensen J.T.
        • Higgins M.
        • et al.
        Usefulness of cardiovascular family history data for populationbased preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study).
        Am J Cardiol. 2001; 87: 129-135
        • Botkin J.R.
        • Teutsch S.M.
        • Kaye C.I.
        • Hayes M.
        • Haddow J.E.
        • Bradley L.A.
        • et al.
        Outcomes of interest in evidence-based evaluations of genetic tests.
        Genet Med. 2010; 12: 228-235
        • Huijgen R.
        • Kindt I.
        • Verhoeven S.B.
        • Sijbrands E.J.
        • Vissers M.N.
        • Kastelein J.J.
        • et al.
        Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.
        PLoS One. 2010; 5: e9220
        • Jousilahti P.
        • Vartiainen E.
        • Tuomilehto J.
        • Puska P.
        Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14,786 middle-aged men and women in Finland.
        Circulation. 1999; 99: 1165-1172
        • Rayner M.
        • Allender S.
        • Scarborough P.
        Cardiovascular disease in Europe.
        Eur J Cardiovasc Prev Rehabil. 2009; 16: S43-S47
        • Wald N.J.
        • Law M.R.
        A strategy to reduce cardiovascular disease by more than 80%.
        BMJ. 2003; 326: 1419
        • Schisterman E.F.
        • Whitcomb B.W.
        Coronary age as a risk factor in the modified Framingham risk score.
        BMC Med Imaging. 2004; 4: 1
        • Weintraub W.S.
        • Diamond G.A.
        Predicting cardiovascular events with coronary calcium scoring.
        N Engl J Med. 2008; 358: 1394-1396
        • Lawlor D.A.
        • Ebrahim S.
        • Davey Smith G.
        Sex matters: secular, geographical trends in sex differences in coronary heart disease mortality.
        BMJ. 2001; 323: 541-545
        • Mosca L.
        • Benjamin E.J.
        • Berra K.
        • Bezanson J.L.
        • Dolor R.J.
        • Lloyd-Jones D.M.
        • et al.
        Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association.
        Circulation. 2011; 123: 1243-1262
        • Hsia J.
        • Rodabough R.J.
        • Manson J.E.
        • Liu S.
        • Freiberg M.S.
        • Graettinger W.
        • et al.
        Evaluation of the American Heart Association cardiovascular disease prevention guideline for women.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 128-134
        • Rollman B.L.
        • Belnap B.H.
        • LeMenager M.S.
        • Mazumdar S.
        • Houck P.R.
        • Counihan P.J.
        • et al.
        Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial.
        JAMA. 2009; 302: 2095-2103
        • Davidson K.W.
        • Rieckmann N.
        • Clemow L.
        • Schwartz J.E.
        • Shimbo D.
        • Medina V.
        • et al.
        Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial.
        Arch Intern Med. 2010; 170: 600-608
        • Katon W.J.
        • Lin E.H.
        • Von Korff M.
        • Ciechanowski P.
        • Ludman E.J.
        • Young B.
        • et al.
        Collaborative care for patients with depression and chronic illnesses.
        N Engl J Med. 2010; 363: 2611-2620
        • Woodward M.
        • Brindle P.
        • Tunstall-Pedoe H.
        Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC).
        Heart. 2007; 93: 172-176
        • Stringhini S.
        • Sabia S.
        • Shipley M.
        • Brunner E.
        • Nabi H.
        • Kivimaki M.
        • et al.
        Association of socioeconomic position with health behaviors and mortality.
        JAMA. 2010; 303: 1159-1166
        • Tonne C.
        • Schwartz J.
        • Mittleman M.
        • Melly S.
        • Suh H.
        • Goldberg R.
        Long-term survival after acute myocardial infarction is lower in more deprived neighborhoods.
        Circulation. 2005; 111: 3063-3070
        • Albert M.A.
        • Glynn R.J.
        • Buring J.
        • Ridker P.M.
        Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
        Circulation. 2006; 114: 2619-2626
        • Rahimi A.R.
        • Spertus J.A.
        • Reid K.J.
        • Bernheim S.M.
        • Krumholz H.M.
        Financial barriers to health care and outcomes after acute myocardial infarction.
        JAMA. 2007; 297: 1063-1072
        • Mookadam F.
        • Arthur H.M.
        Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview.
        Arch Intern Med. 2004; 164: 1514-1518
        • Lett H.S.
        • Blumenthal J.A.
        • Babyak M.A.
        • Strauman T.J.
        • Robins C.
        • Sherwood A.
        Social support and coronary heart disease: epidemiologic evidence and implications for treatment.
        Psychosom Med. 2005; 67: 869-878
        • Eller N.H.
        • Netterstrom B.
        • Gyntelberg F.
        • Kristensen T.S.
        • Nielsen F.
        • Steptoe A.
        • et al.
        Work-related psychosocial factors and the development of ischemic heart disease: a systematic review.
        Cardiol Rev. 2009; 17: 83-97
        • De Vogli R.
        • Ferrie J.E.
        • Chandola T.
        • Kivimaki M.
        • Marmot M.G.
        Unfairness and health: evidence from the Whitehall II study.
        J Epidemiol Community Health. 2007; 61: 513-518
        • Eaker E.D.
        • Sullivan L.M.
        • Kelly-Hayes M.
        • Sr D’Agostino RB.
        • Benjamin E.J.
        Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study.
        Psychosom Med. 2007; 69: 509-513
        • Orth-Gomer K.
        • Wamala S.P.
        • Horsten M.
        • Schenck-Gustafsson K.
        • Schneiderman N.
        • Mittleman M.A.
        Marital stress worsens prognosis in women with coronary heart disease: the Stockholm Female Coronary Risk Study.
        JAMA. 2000; 284: 3008-3014
        • Rugulies R.
        Depression as a predictor for coronary heart disease. a review and meta-analysis.
        Am J Prev Med. 2002; 23: 51-61
        • Wulsin L.R.
        • Singal B.M.
        Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.
        Psychosom Med. 2003; 65: 201-210
        • Nicholson A.
        • Kuper H.
        • Hemingway H.
        Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146,538 participants in 54 observational studies.
        Eur Heart J. 2006; 27: 2763-2774
        • Barth J.
        • Schumacher M.
        • Herrmann-Lingen C.
        Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis.
        Psychosom Med. 2004; 66: 802-813
        • van Melle J.P.
        • de Jonge P.
        • Spijkerman T.A.
        • Tijssen J.G.
        • Ormel J.
        • van Veldhuisen D.J.
        • et al.
        Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis.
        Psychosom Med. 2004; 66: 814-822
        • Frasure-Smith N.
        • Lesperance F.
        • Gravel G.
        • Masson A.
        • Juneau M.
        • Talajic M.
        • et al.
        Social support, depression, mortality during the first year after myocardial infarction.
        Circulation. 2000; 101: 1919-1924
        • Horsten M.
        • Mittleman M.A.
        • Wamala S.P.
        • Schenck-Gustafsson K.
        • Orth-Gomer K.
        Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study.
        Eur Heart J. 2000; 21: 1072-1080
        • Smoller J.W.
        • Pollack M.H.
        • Wassertheil-Smoller S.
        • Jackson R.D.
        • Oberman A.
        • Wong N.D.
        • et al.
        Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women’s Health Initiative Observational Study.
        Arch Gen Psychiatry. 2007; 64: 1153-1160
        • Chen Y.H.
        • Tsai S.Y.
        • Lee H.C.
        • Lin H.C.
        Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study.
        Psychosom Med. 2009; 71: 798-804
        • Frasure-Smith N.
        • Lesperance F.
        Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.
        Arch Gen Psychiatry. 2008; 65: 62-71
        • Shibeshi W.A.
        • Young-Xu Y.
        • Blatt C.M.
        Anxiety worsens prognosis in patients with coronary artery disease.
        J Am Coll Cardiol. 2007; 49: 2021-2027
        • Szekely A.
        • Balog P.
        • Benko E.
        • Breuer T.
        • Szekely J.
        • Kertai M.D.
        • et al.
        Anxiety predicts mortality and morbidity after coronary artery and valve surgery—a 4-year follow-up study.
        Psychosom Med. 2007; 69: 625-631
        • Meyer T.
        • Buss U.
        • Herrmann-Lingen C.
        Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality.
        Psychosom Med. 2010; 72: 9-15
        • Roest A.M.
        • Martens E.J.
        • de Jonge P.
        • Denollet J.
        Anxiety and risk of incident coronary heart disease: a meta-analysis.
        J Am Coll Cardiol. 2010; 56: 38-46
        • Roest A.M.
        • Martens E.J.
        • Denollet J.
        • de Jonge P.
        Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis.
        Psychosom Med. 2010; 72: 563-569
        • Chida Y.
        • Steptoe A.
        The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence.
        J Am Coll Cardiol. 2009; 53: 936-946
        • Denollet J.
        • Gidron Y.
        • Vrints C.J.
        • Conraads V.M.
        Anger, suppressed anger, and risk of adverse events in patients with coronary artery disease.
        Am J Cardiol. 2010; 105: 1555-1560
        • Denollet J.
        • Schiffer A.A.
        • Spek V.
        A general propensity to psychological distress affects cardiovascular outcomes: evidence from research on the type D (distressed) personality profile.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 546-557
        • Wamala S.P.
        • Mittleman M.A.
        • Schenck-Gustafsson K.
        • Orth-Gomer K.
        Potential explanations for the educational gradient in coronary heart disease: a population-based case–control study of Swedish women.
        Am J Public Health. 1999; 89: 315-321
        • Chandola T.
        • Britton A.
        • Brunner E.
        • Hemingway H.
        • Malik M.
        • Kumari M.
        • et al.
        Work stress and coronary heart disease: what are the mechanisms?.
        Eur Heart J. 2008; 29: 640-648
        • Rozanski A.
        • Blumenthal J.A.
        • Davidson K.W.
        • Saab P.G.
        • Kubzansky L.
        The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology.
        J Am Coll Cardiol. 2005; 45: 637-651
        • Whooley M.A.
        • de Jonge P.
        • Vittinghoff E.
        • Otte C.
        • Moos R.
        • Carney R.M.
        • et al.
        Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.
        JAMA. 2008; 300: 2379-2388
        • Steptoe A.
        • Marmot M.
        The role of psychobiological pathways in socio-economic inequalities in cardiovascular disease risk.
        Eur Heart J. 2002; 23: 13-25
        • Cohen H.W.
        • Gibson G.
        • Alderman M.H.
        Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.
        Am J Med. 2000; 108: 2-8
        • Hippisley-Cox J.
        • Pringle M.
        • Hammersley V.
        • Crown N.
        • Wynn A.
        • Meal A.
        • et al.
        Antidepressants as risk factor for ischaemic heart disease: case–control study in primary care.
        BMJ. 2001; 323: 666-669
        • Albus C.
        • Jordan J.
        • Herrmann-Lingen C.
        Screening for psychosocial risk factors in patients with coronary heart disease—recommendations for clinical practice.
        Eur J Cardiovasc Prev Rehabil. 2004; 11: 75-79
        • Thombs B.D.
        • de Jonge P.
        • Coyne J.C.
        • Whooley M.A.
        • Frasure-Smith N.
        • Mitchell A.J.
        • et al.
        Depression screening and patient outcomes in cardiovascular care: a systematic review.
        JAMA. 2008; 300: 2161-2171
        • Berger J.S.
        • Jordan C.O.
        • Lloyd-Jones D.
        • Blumenthal R.S.
        Screening for cardiovascular risk in asymptomatic patients.
        J Am Coll Cardiol. 2010; 55: 1169-1177
        • Kaptoge S.
        • Di Angelantonio E.
        • Lowe G.
        • Pepys M.B.
        • Thompson S.G.
        • Collins R.
        • et al.
        C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
        Lancet. 2010; 375: 132-140
        • Kaptoge S.
        • White I.R.
        • Thompson S.G.
        • Wood A.M.
        • Lewington S.
        • Lowe G.D.
        • et al.
        Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.
        Am J Epidemiol. 2007; 166: 867-879
        • Clarke R.
        • Halsey J.
        • Lewington S.
        • Lonn E.
        • Armitage J.
        • Manson J.E.
        • et al.
        Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals.
        Arch Intern Med. 2010; 170: 1622-1631
        • Garza C.A.
        • Montori V.M.
        • McConnell J.P.
        • Somers V.K.
        • Kullo I.J.
        • Lopez-Jimenez F.
        Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.
        Mayo Clin Proc. 2007; 82: 159-165
        • O’Leary D.H.
        • Polak J.F.
        • Kronmal R.A.
        • Manolio T.A.
        • Burke G.L.
        • Wolfson Jr., S.K.
        Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.
        N Engl J Med. 1999; 340: 14-22
        • Chambless L.E.
        • Heiss G.
        • Folsom A.R.
        • Rosamond W.
        • Szklo M.
        • Sharrett A.R.
        • et al.
        Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993.
        Am J Epidemiol. 1997; 146: 483-494
        • Sramek A.
        • Bosch J.G.
        • Reiber J.H.
        • Van Oostayen J.A.
        • Rosendaal F.R.
        Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries.
        Invest Radiol. 2000; 35: 699-706
        • Hiatt W.R.
        Medical treatment of peripheral arterial disease and claudication.
        N Engl J Med. 2001; 344: 1608-1621
        • McDermott M.M.
        • Greenland P.
        • Liu K.
        • Guralnik J.M.
        • Celic L.
        • Criqui M.H.
        • et al.
        The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study.
        Ann Intern Med. 2002; 136: 873-883
        • Vogt M.T.
        • Cauley J.A.
        • Newman A.B.
        • Kuller L.H.
        • Hulley S.B.
        Decreased ankle/arm blood pressure index and mortality in elderly women.
        JAMA. 1993; 270: 465-469
        • Schiffrin E.L.
        • Lipman M.L.
        • Mann J.F.
        Chronic kidney disease: effects on the cardiovascular system.
        Circulation. 2007; 116: 85-97
        • van Werkhoven J.M.
        • Gaemperli O.
        • Schuijf J.D.
        • Jukema J.W.
        • Kroft L.J.
        • Leschka S.
        • et al.
        Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood.
        Heart. 2009; 95: 1607-1611
        • Mollmann H.
        • Liebetrau C.
        • Nef H.M.
        • Hamm C.W.
        The Swedish paradox: or is there really no gender difference in acute coronary syndromes?.
        Eur Heart J. 2011; 32: 3070-3072
        • Gibbons R.J.
        • Abrams J.
        • Chatterjee K.
        • Daley J.
        • Deedwania P.C.
        • Douglas J.S.
        • et al.
        ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American heart association task force on practice guidelines (Committee on the management of patients with chronic stable angina).
        Circulation. 2003; 107: 149-158
        • Kodama S.
        • Saito K.
        • Tanaka S.
        • Maki M.
        • Yachi Y.
        • Asumi M.
        • et al.
        Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
        JAMA. 2009; 301: 2024-2035
        • Achenbach S.
        • Daniel W.G.
        Noninvasive coronary angiography—an acceptable alternative?.
        N Engl J Med. 2001; 345: 1909-1910
        • van Geuns R.J.
        • Oudkerk M.
        • Rensing B.J.
        • Bongaerts A.H.
        • de Bruin H.G.
        • Wielopolski P.A.
        • et al.
        Comparison of coronary imaging between magnetic resonance imaging and electron beam computed tomography.
        Am J Cardiol. 2002; 90: 58-63
        • Miao C.
        • Chen S.
        • Macedo R.
        • Lai S.
        • Liu K.
        • Li D.
        • et al.
        Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population: MESA (Multi-Ethnic Study of Atherosclerosis).
        J Am Coll Cardiol. 2009; 53: 1708-1715
        • Shinnar M.
        • Fallon J.T.
        • Wehrli S.
        • Levin M.
        • Dalmacy D.
        • Fayad Z.A.
        • et al.
        The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization.
        Arterioscler Thromb Vasc Biol. 1999; 19: 2756-2761
        • Kim W.Y.
        • Stuber M.
        • Bornert P.
        • Kissinger K.V.
        • Manning W.J.
        • Botnar R.M.
        Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease.
        Circulation. 2002; 106: 296-299
        • Greenland P.
        • Abrams J.
        • Aurigemma G.P.
        • Bond M.G.
        • Clark L.T.
        • Criqui M.H.
        • et al.
        Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: writing Group III.
        Circulation. 2000; 101: E16-E22
        • Tinana A.
        • Mintz G.S.
        • Weissman N.J.
        Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments.
        Am J Cardiol. 2002; 89: 757-760
        • Burke A.P.
        • Kolodgie F.D.
        • Farb A.
        • Weber D.
        • Virmani R.
        Morphological predictors of arterial remodeling in coronary atherosclerosis.
        Circulation. 2002; 105: 297-303
        • Schmermund A.
        • Schwartz R.S.
        • Adamzik M.
        • Sangiorgi G.
        • Pfeifer E.A.
        • Rumberger J.A.
        • et al.
        Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with ‘healthy’ subjects dying out of hospital.
        Atherosclerosis. 2001; 155: 499-508
        • Buffon A.
        • Biasucci L.M.
        • Liuzzo G.
        • D’Onofrio G.
        • Crea F.
        • Maseri A.
        Widespread coronary inflammation in unstable angina.
        N Engl J Med. 2002; 347: 5-12
        • Wang T.J.
        • Larson M.G.
        • Levy D.
        • Benjamin E.J.
        • Kupka M.J.
        • Manning W.J.
        • et al.
        C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study.
        Circulation. 2002; 106: 1189-1191
        • Silber S.
        Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons.
        Int J Cardiol. 2002; 82 (author reply 299): 297-298
        • Callister T.Q.
        • Cooil B.
        • Raya S.P.
        • Lippolis N.J.
        • Russo D.J.
        • Raggi P.
        Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method.
        Radiology. 1998; 208: 807-814
        • Haberl R.
        • Becker A.
        • Leber A.
        • Knez A.
        • Becker C.
        • Lang C.
        • et al.
        Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1764 patients.
        J Am Coll Cardiol. 2001; 37: 451-457
        • Marwan M.
        • Ropers D.
        • Pflederer T.
        • Daniel W.G.
        • Achenbach S.
        Clinical characteristics of patients with obstructive coronary lesions in the absence of coronary calcification: an evaluation by coronary CT angiography.
        Heart. 2009; 95: 1056-1060
        • Arad Y.
        • Spadaro L.A.
        • Goodman K.
        • Newstein D.
        • Guerci A.D.
        Prediction of coronary events with electron beam computed tomography.
        J Am Coll Cardiol. 2000; 36: 1253-1260
        • Hecht H.S.
        • Superko H.R.
        Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.
        J Am Coll Cardiol. 2001; 37: 1506-1511
        • Hadamitzky M.
        • Freissmuth B.
        • Meyer T.
        • Hein F.
        • Kastrati A.
        • Martinoff S.
        • et al.
        Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease.
        JACC Cardiovasc Imaging. 2009; 2: 404-411
        • Vliegenthart R.
        • Oudkerk M.
        • Song B.
        • van der Kuip D.A.
        • Hofman A.
        • Witteman J.C.
        Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study.
        Eur Heart J. 2002; 23: 1596-1603
        • Perrone-Filardi P.
        • Achenbach S.
        • Mohlenkamp S.
        • Reiner Z.
        • Sambuceti G.
        • Schuijf J.D.
        • et al.
        Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology.
        Eur Heart J. 2011; 32 (1993a, 1993b): 1986-1993
        • Safar M.E.
        • Blacher J.
        • Jankowski P.
        Arterial stiffness, pulse pressure, and cardiovascular disease—is it possible to break the vicious circle?.
        Atherosclerosis. 2011; 218: 263-271
        • Mitchell G.F.
        • Hwang S.J.
        • Vasan R.S.
        • Larson M.G.
        • Pencina M.J.
        • Hamburg N.M.
        • et al.
        Arterial stiffness and cardiovascular events: the Framingham heart study.
        Circulation. 2010; 121: 505-511
        • Fowkes F.G.
        • Price J.F.
        • Stewart M.C.
        • Butcher I.
        • Leng G.C.
        • Pell A.C.
        • et al.
        Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.
        JAMA. 2010; 303: 841-848
        • Tedeschi-Reiner E.
        • Reiner Z.
        • Sonicki Z.
        Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
        Croat Med J. 2004; 45: 333-337
        • Fox C.S.
        • Muntner P.
        • Chen A.Y.
        • Alexander K.P.
        • Roe M.T.
        • Cannon C.P.
        • et al.
        Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry.
        Circulation. 2010; 121: 357-365
        • Colhoun H.M.
        • Betteridge D.J.
        • Durrington P.N.
        • Hitman G.A.
        • Neil H.A.
        • Livingstone S.J.
        • et al.
        Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
        Lancet. 2004; 364: 685-696
        • Gottlieb D.J.
        • Yenokyan G.
        • Newman A.B.
        • O’Connor G.T.
        • Punjabi N.M.
        • Quan S.F.
        • et al.
        Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study.
        Circulation. 2010; 122: 352-360
        • Cassar A.
        • Morgenthaler T.I.
        • Lennon R.J.
        • Rihal C.S.
        • Lerman A.
        Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention.
        J Am Coll Cardiol. 2007; 50: 1310-1314
        • Gupta B.P.
        • Murad M.H.
        • Clifton M.M.
        • Prokop L.
        • Nehra A.
        • Kopecky S.L.
        The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: asystematic review and meta-analysis.
        Arch Intern Med. 2011; 171: 1797-1803
        • Hansson G.K.
        Inflammation, atherosclerosis, and coronary artery disease.
        N Engl J Med. 2005; 352: 1685-1695
        • Nichol K.L.
        • Nordin J.
        • Mullooly J.
        • Lask R.
        • Fillbrandt K.
        • Iwane M.
        Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.
        N Engl J Med. 2003; 348: 1322-1332
        • Van de Werf F.
        • Bax J.
        • Betriu A.
        • Blomstrom-Lundqvist C.
        • Crea F.
        • Falk V.
        • et al.
        Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-Segment elevation acute myocardial infarction of the European society of cardiology.
        Eur Heart J. 2008; 29: 2909-2945
        • McCullough P.A.
        • Jurkovitz C.T.
        • Pergola P.E.
        • McGill J.B.
        • BrownWW Collins AJ.
        • Chen S.C.
        • et al.
        Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).
        Arch Intern Med. 2007; 167: 1122-1129
        • Baigent C.
        • Landray M.J.
        • Reith C.
        • Emberson J.
        • Wheeler D.C.
        • Tomson C.
        • et al.
        The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
        Lancet. 2011; 377: 2181-2192
        • Young T.
        • Palta M.
        • Dempsey J.
        • Skatrud J.
        • Weber S.
        • Badr S.
        The occurrence of sleep-disordered breathing among middle-aged adults.
        N Engl J Med. 1993; 328: 1230-1235
        • Shamsuzzaman A.S.
        • Gersh B.J.
        • Somers V.K.
        Obstructive sleep apnea: implications for cardiac and vascular disease.
        JAMA. 2003; 290: 1906-1914
        • Mooe T.
        • Franklin K.A.
        • Holmstrom K.
        • Rabben T.
        • Wiklund U.
        Sleep-disordered breathing and coronary artery disease: long-term prognosis.
        Am J Respir Crit Care Med. 2001; 164: 1910-1913
        • Milleron O.
        • Pilliere R.
        • Foucher A.
        • de Roquefeuil F.
        • Aegerter P.
        • Jondeau G.
        • et al.
        Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study.
        Eur Heart J. 2004; 25: 728-734
        • Feldman H.A.
        • Goldstein I.
        • Hatzichristou D.G.
        • Krane R.J.
        • McKinlay J.B.
        Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.
        J Urol. 1994; 151: 54-61
        • Benet A.E.
        • Melman A.
        The epidemiology of erectile dysfunction.
        Urol Clin North Am. 1995; 22: 699-709
        • Lue T.F.
        Erectile dysfunction.
        N Engl J Med. 2000; 342: 1802-1813
        • Feldman H.A.
        • Johannes C.B.
        • Derby C.A.
        • Kleinman K.P.
        • Mohr B.A.
        • Araujo A.B.
        • et al.
        Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study.
        Prev Med. 2000; 30: 328-338
        • Jackson G.
        Erectile dysfunction: a marker of silent coronary artery disease.
        Eur Heart J. 2006; 27: 2613-2614
        • Araujo A.B.
        • Hall S.A.
        • Ganz P.
        • Chiu G.R.
        • Rosen R.C.
        • Kupelian V.
        • et al.
        Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?.
        J Am Coll Cardiol. 2010; 55: 350-356
        • Gelfand J.M.
        • Neimann A.L.
        • Shin D.B.
        • Wang X.
        • Margolis D.J.
        • Troxel A.B.
        Risk of myocardial infarction in patients with psoriasis.
        JAMA. 2006; 296: 1735-1741
        • Mehta N.N.
        • Azfar R.S.
        • Shin D.B.
        • Neimann A.L.
        • Troxel A.B.
        • Gelfand J.M.
        Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.
        Eur Heart J. 2010; 31: 1000-1006
        • Westlake S.L.
        • Colebatch A.N.
        • Baird J.
        • Kiely P.
        • Quinn M.
        • Choy E.
        • et al.
        The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
        Rheumatology (Oxford). 2010; 49: 295-307
        • Prodanovich S.
        • Ma F.
        • Taylor J.R.
        • Pezon C.
        • Fasihi T.
        • Kirsner R.S.
        Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
        J Am Acad Dermatol. 2005; 52: 262-267
        • Recio-Mayoral A.
        • Mason J.C.
        • Kaski J.C.
        • Rubens M.B.
        • Harari O.A.
        • Camici P.G.
        Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease.
        Eur Heart J. 2009; 30: 1837-1843
        • Tonetti M.S.
        • D’Aiuto F.
        • Nibali L.
        • Donald A.
        • Storry C.
        • Parkar M.
        • et al.
        Treatment of periodontitis and endothelial function.
        N Engl J Med. 2007; 356: 911-920
        • Darby S.
        • McGale P.
        • Peto R.
        • Granath F.
        • Hall P.
        • Ekbom A.
        Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90,000 Swedish women.
        BMJ. 2003; 326: 256-257
        • Smith G.L.
        • Smith B.D.
        • Buchholz T.A.
        • Giordano S.H.
        • Garden A.S.
        • Woodward W.A.
        • et al.
        Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.
        J Clin Oncol. 2008; 26: 5119-5125
        • Fajardo L.F.
        Is the pathology of radiation injury different in small vs large blood vessels?.
        Cardiovasc Radiat Med. 1999; 1: 108-110
        • Hunt S.A.
        • Haddad F.
        The changing face of heart transplantation.
        J Am Coll Cardiol. 2008; 52: 587-598
        • Dusseldorp E.
        • van Elderen T.
        • Maes S.
        • Meulman J.
        • Kraaij V.
        A meta-analysis of psychoeduational programs for coronary heart disease patients.
        Health Psychol. 1999; 18: 506-519
        • Rubak S.
        • Sandbaek A.
        • Lauritzen T.
        • Christensen B.
        Motivational interviewing: a systematic review and meta-analysis.
        Br J Gen Pract. 2005; 55: 305-312
        • Clark A.M.
        • Hartling L.
        • Vandermeer B.
        • McAlister F.A.
        Meta-analysis: secondary prevention programs for patients with coronary artery disease.
        Ann Intern Med. 2005; 143: 659-672
        • Auer R.
        • Gaume J.
        • Rodondi N.
        • Cornuz J.
        • Ghali W.A.
        Efficacy of in-hospital multidimensional interventions of secondary prevention after acute coronary syndrome: a systematic review and meta-analysis.
        Circulation. 2008; 117: 3109-3117
        • Linden W.
        • Phillips M.J.
        • Leclerc J.
        Psychological treatment of cardiac patients: a meta-analysis.
        Eur Heart J. 2007; 28: 2972-2984
        • Rees K.
        • Bennett P.
        • West R.
        • Davey S.G.
        • Ebrahim S.
        Psychological interventions for coronary heart disease.
        Cochrane Database Syst Rev. 2004; 2: CD002902
        • Rollnick S.
        • Butler C.C.
        • Kinnersley P.
        • Gregory J.
        • Mash B.
        Motivational interviewing.
        BMJ. 2010; 340: c1900
        • Artinian N.T.
        • Fletcher G.F.
        • Mozaffarian D.
        • Kris-Etherton P.
        • Van Horn L.
        • Lichtenstein A.H.
        • et al.
        Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association.
        Circulation. 2010; 122: 406-441
        • US Preventive Services Task Force
        Guide to clinical preventive Services.
        2nd ed. US Department of Health & Human Services, Washington, DC1996
        • Balady G.J.
        • Williams M.A.
        • Ades P.A.
        • Bittner V.
        • Comoss P.
        • Foody J.M.
        • et al.
        Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American heart association exercise, cardiac rehabilitation, and prevention committee, the Council on clinical cardiology; the Councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the American association of cardiovascular and pulmonary rehabilitation.
        Circulation. 2007; 115: 2675-2682
        • Piepoli M.F.
        • Corra U.
        • Benzer W.
        • Bjarnason-Wehrens B.
        • Dendale P.
        • Gaita D.
        • et al.
        Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the cardiac rehabilitation section of the European association of cardiovascular prevention and rehabilitation.
        Eur J Cardiovasc Prev Rehabil. 2010; 17: 1-17
        • Burell G.
        • Granlund B.
        Women’s hearts need special treatment.
        Int J Behav Med. 2002; 9: 228-242
        • Doll R.
        • Peto R.
        • Wheatley K.
        • Gray R.
        • Sutherland I.
        Mortality in relation to smoking: 40 years’ observations on male British doctors.
        BMJ. 1994; 309: 901-911
        • Thun M.J.
        • Myers D.G.
        • Day-Lally C.
        • Namboodin M.M.
        • Calle E.E.
        • Flanders W.D.
        • et al.
        Age and the exposure–response relationships between cigarette smoking and premature death in cancer prevention study II. Changes in cigarette-related disease risks and their implications for prevention and control. Smoking and tobacco control Monograph No. 8.
        US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD1997 (383–413)
        • He J.
        • Vupputuri S.
        • Allen K.
        • Prerost M.R.
        • Hughes J.
        • Whelton P.K.
        Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies.
        N Engl J Med. 1999; 340: 920-926
        • Lightwood J.M.
        • Glantz S.A.
        Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke.
        Circulation. 2009; 120: 1373-1379
        • Center for Disease Control and Prevention
        How tobacco smoke causes disease: the Biology and behavioural basis for smoking-attributable disease.
        A Rep Surgeon Gen. 2010;
        • Lancaster T.
        • Stead L.
        Physician advice for smoking cessation.
        Cochrane Database Syst Rev. 2004; 4: CD000165.
        • Stead L.F.
        • Perera R.
        • Bullen C.
        • Mant D.
        • Lancaster T.
        Nicotine replacement therapy for smoking cessation.
        Cochrane Database Syst Rev. 2008; 1: CD000146
        • Edwards R.
        The problem of tobacco smoking.
        BMJ. 2004; 328: 217-219
        • Prescott E.
        • Hippe M.
        • Schnohr P.
        • Hein H.O.
        • Vestbo J.
        Smoking and risk of myocardial infarction in women and men: longitudinal population study.
        BMJ. 1998; 316: 1043-1047
        • Huisman M.
        • Kunst A.E.
        • Mackenbach J.P.
        Inequalities in the prevalence of smoking in the European Union: comparing education and income.
        Prev Med. 2005; 40: 756-764
        • Giskes K.
        • Kunst A.E.
        • Benach J.
        • Borrell C.
        • Costa G.
        • Dahl E.
        • et al.
        Trends in smoking behaviour between 1985 and 2000 in nine European countries by education.
        J Epidemiol Community Health. 2005; 59: 395-401
        • Mucha L.
        • Stephenson J.
        • Morandi N.
        • Dirani R.
        Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking.
        Gend Med. 2006; 3: 279-291
        • Benowitz N.L.
        • Lessov-Schlaggar C.N.
        • Swan G.E.
        • Jacob 3rd, P.
        Female sex and oral contraceptive use accelerate nicotine metabolism.
        Clin Pharmacol Ther. 2006; 79: 480-488
        • Prescott E.
        • Scharling H.
        • Osler M.
        • Schnohr P.
        Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 49 men and women in The Copenhagen City Heart Study.
        J Epidemiol Community Health. 2002; 56: 702-706
        • WHO Study Group on Tobacco Product Regulation TobReg
        Waterpipe tobacco smoking: health effects, research needs and recommended actions by Regulators.
        2005
        • Akl E.A.
        • Gaddam S.
        • Gunukula S.K.
        • Honeine R.
        • Jaoude P.A.
        • Irani J.
        The effects of waterpipe tobacco smoking on health outcomes: a systematic review.
        Int J Epidemiol. 2010; 39: 834-857
        • Boffetta P.
        • Straif K.
        Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis.
        BMJ. 2009; 339: b3060
        • Law M.R.
        • Morris J.K.
        • Wald N.J.
        Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence.
        BMJ. 1997; 315: 973-980
        • Raupach T.
        • Schafer K.
        • Konstantinides S.
        • Andreas S.
        Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm.
        Eur Heart J. 2006; 27: 386-392
        • Steenland K.
        Risk assessment for heart disease and workplace ETS exposure among nonsmokers.
        Environ Health Perspect. 1999; 107: 859-863
        • Ambrose J.A.
        • Barua R.S.
        The pathophysiology of cigarette smoking and cardiovascular disease: an update.
        J Am Coll Cardiol. 2004; 43: 1731-1737
        • Armani C.
        • Landini Jr., L.
        • Leone A.
        Molecular and biochemical changes of the cardiovascular system due to smoking exposure.
        Curr Pharm Des. 2009; 15: 1038-1053
        • Rahman M.M.
        • Laher I.
        Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms.
        Curr Vasc Pharmacol. 2007; 5: 276-292
        • Adams M.R.
        • Robinson J.
        • McCredie R.
        • Seale J.P.
        • Sorensen K.E.
        • Deanfield J.E.
        • et al.
        Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis.
        J Am Coll Cardiol. 1998; 32: 123-127
        • Celermajer D.S.
        • Sorensen K.E.
        • Georgakopoulos D.
        • Bull C.
        • Thomas O.
        • Robinson J.
        • et al.
        Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.
        Circulation. 1993; 88: 2149-2155
        • Yamaguchi Y.
        • Matsuno S.
        • Kagota S.
        • Haginaka J.
        • Kunitomo M.
        Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits.
        Atherosclerosis. 2001; 156: 109-117
        • Taylor B.V.
        • Oudit G.Y.
        • Kalman P.G.
        • Liu P.
        Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system.
        Can J Cardiol. 1998; 14: 1129-1139
        • Bermudez E.A.
        • Rifai N.
        • Buring J.E.
        • Manson J.E.
        • Ridker P.M.
        Relation between markers of systemic vascular inflammation and smoking in women.
        Am J Cardiol. 2002; 89: 1117-1119
        • Benowitz N.L.
        • Fitzgerald G.A.
        • Wilson M.
        • Zhang Q.
        Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
        J Am Coll Cardiol. 1993; 22: 1159-1167
        • Newby D.E.
        • Wright R.A.
        • Labinjoh C.
        • Ludlam C.A.
        • Fox K.A.
        • Boon N.A.
        • et al.
        Endothelial dysfunction impaired endogenous fibrinolysis cigarette smoking: a mechanism for arterial thrombosis myocardial infarction.
        Circulation. 1999; 99: 1411-1415
        • Newby D.E.
        • McLeod A.L.
        • Uren N.G.
        • Flint L.
        • Ludlam C.A.
        • Webb D.J.
        • et al.
        Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis.
        Circulation. 2001; 103: 1936-1941
        • Simpson A.J.
        • Gray R.S.
        • Moore N.R.
        • Booth N.A.
        The effects of chronic smoking on the fibrinolytic potential of plasma and platelets.
        Br J Haematol. 1997; 97: 208-213
        • Weber C.
        • Erl W.
        • Weber K.
        • Weber P.C.
        Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers.
        Circulation. 1996; 93: 1488-1492
        • Weber C.
        • Erl W.
        • Weber P.C.
        Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b.
        Biochem Biophys Res Commun. 1995; 206: 621-628
        • Yamaguchi Y.
        • Matsuno S.
        • Kagota S.
        • Haginaka J.
        • Kunitomo M.
        Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin.
        Atherosclerosis. 2004; 172: 259-265
        • Yamaguchi Y.
        • Haginaka J.
        • Morimoto S.
        • Fujioka Y.
        • Kunitomo M.
        Facilitated nitration and oxidation of LDL in cigarette smokers.
        Eur J Clin Invest. 2005; 35: 186-193
        • Moreno Jr., H.
        • Chalon S.
        • Urae A.
        • Tangphao O.
        • Abiose A.K.
        • Hoffman B.B.
        • et al.
        Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation.
        Am J Physiol. 1998; 275: H1040-H1045
        • Morita H.
        • Ikeda H.
        • Haramaki N.
        • Eguchi H.
        • Imaizumi T.
        Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers.
        J Am Coll Cardiol. 2005; 45: 589-594
        • Hanna S.T.
        Nicotine effect on cardiovascular system and ion channels.
        J Cardiovasc Pharmacol. 2006; 47: 348-358
        • Joseph A.M.
        • Norman S.M.
        • Ferry L.H.
        • Prochazka A.V.
        • Westman E.C.
        • Steele B.G.
        • et al.
        The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.
        N Engl J Med. 1996; 335: 1792-1798
        • Joseph A.M.
        • Fu S.S.
        Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease.
        Prog Cardiovasc Dis. 2003; 45: 429-441
        • International Agency for Research on Cancer
        Tobacco control: reversal of risk after quitting smoking.
        IARC handbooks of cancer prevention. Vol. 11. IARC, Lyon2007
        • Critchley J.
        • Capewell S.
        Smoking cessation for the secondary prevention of coronary heart disease.
        Cochrane Database Syst Rev. 2004; 1: CD003041
        • Chow C.K.
        • Jolly S.
        • Rao-Melacini P.
        • Fox K.A.
        • Anand S.S.
        • Yusuf S.
        Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes.
        Circulation. 2010; 121: 750-758
        • Anthonisen N.R.
        • Skeans M.A.
        • Wise R.A.
        • Manfreda J.
        • Kanner R.E.
        • Connett J.E.
        The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.
        Ann Intern Med. 2005; 142: 233-239
        • Mohiuddin S.M.
        • Mooss A.N.
        • Hunter C.B.
        • Grollmes T.L.
        • Cloutier D.A.
        • Hilleman D.E.
        Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease.
        Chest. 2007; 131: 446-452
        • National Institute for Health and Clinical Excellence
        NICE public health guidance 10. Smoking cessation services in primary care, Pharmacies, local authorities and Workplaces, particularly for Manual working groups, pregnant women and hard to reach communities.
        • Stead L.F.
        • Bergson G.
        • Lancaster T.
        Physician advice for smoking cessation.
        Cochrane Database Syst Rev. 2008; 2: CD000165
        • Rigotti N.A.
        • Munafo M.R.
        • Stead L.F.
        Smoking cessation interventions for hospitalized smokers: a systematic review.
        Arch Intern Med. 2008; 168: 1950-1960
        • Heatherton T.F.
        • Kozlowski L.T.
        • Frecker R.C.
        • Fagerstrom K.O.
        The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance questionnaire.
        Br J Addict. 1991; 86: 1119-1127
        • Ludvig J.
        • Miner B.
        • Eisenberg M.J.
        Smoking cessation in patients with coronary artery disease.
        Am Heart J. 2005; 149: 565-572
        • Hughes J.R.
        • Stead L.F.
        • Lancaster T.
        Antidepressants for smoking cessation.
        Cochrane Database Syst Rev. 2007; 1: CD000031
        • Cahill K.
        • Stead L.F.
        • Lancaster T.
        Nicotine receptor partial agonists for smoking cessation.
        Cochrane Database Syst Rev. 2008; 3: CD006103
        • Rigotti N.A.
        • Pipe A.L.
        • Benowitz N.L.
        • Arteaga C.
        • Garza D.
        • Tonstad S.
        Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.
        Circulation. 2010; 121: 221-229
        • Cahill K.
        • Stead L.F.
        • Lancaster T.
        Nicotine receptor partial agonists for smoking cessation.
        Cochrane Database Syst Rev. 2010; 12: CD006103
        • Singh S.
        • Loke Y.K.
        • Spangler J.G.
        • Furberg C.D.
        Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.
        CMAJ. 2011; 183: 1359-1366
        • Hawkes N.
        Varenicline raises risk of heart problems, analysis indicates.
        BMJ. 2011; 343: d4428
        • West R.
        • Zatonski W.
        • Cedzynska M.
        • Lewandowska D.
        • Pazik J.
        • Aveyard P.
        • et al.
        Placebo-controlled trial of cytisine for smoking cessation.
        N Engl J Med. 2011; 365: 1193-1200
        • Gourlay S.G.
        • Stead L.F.
        • Benowitz N.L.
        Clonidine for smoking cessation.
        Cochrane Database Syst Rev. 2004; 3: CD000058
        • Stead L.F.
        • Lancaster T.
        Group behaviour therapy programmes for smoking cessation.
        Cochrane Database Syst Rev. 2005; 2: CD001007
        • Lancaster T.
        • Stead L.F.
        Individual behavioural counselling for smoking cessation.
        Cochrane Database Syst Rev. 2005; 2: CD001292
        • Rice V.H.
        • Stead L.F.
        Nursing interventions for smoking cessation.
        Cochrane Database Syst Rev. 2004; 1: CD001188
        • White A.R.
        • Rampes H.
        • Campbell J.L.
        Acupuncture and related interventions for smoking cessation.
        Cochrane Database Syst Rev. 2006; 1: CD000009
        • Astrup A.
        • Dyerberg J.
        • Elwood P.
        • Hermansen K.
        • Hu F.B.
        • Jakobsen M.U.
        • et al.
        The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?.
        Am J Clin Nutr. 2011; 93: 684-688
        • He K.
        • Song Y.
        • Daviglus M.L.
        • Liu K.
        • Van Horn L.
        • Dyer A.R.
        • et al.
        Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies.
        Circulation. 2004; 109: 2705-2711
        • Mozaffarian D.
        • Katan M.B.
        • Ascherio A.
        • Stampfer M.J.
        • Willett W.C.
        Trans fatty acids and cardiovascular disease.
        N Engl J Med. 2006; 354: 1601-1613
        • Dauchet L.
        • Amouyel P.
        • Hercberg S.
        • Dallongeville J.
        Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies.
        J Nutr. 2006; 136: 2588-2593
        • He F.J.
        • Nowson C.A.
        • MacGregor G.A.
        Fruit and vegetable consumption and stroke: meta-analysis of cohort studies.
        Lancet. 2006; 367: 320-326
        • Corrao G.
        • Bagnardi V.
        • Zambon A.
        • La Vecchia C.
        A meta-analysis of alcohol consumption and the risk of 15 diseases.
        Prev Med. 2004; 38: 613-619
        • Sofi F.
        • Abbate R.
        • Gensini G.F.
        • Casini A.
        Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis.
        Am J Clin Nutr. 2010; 92: 1189-1196
        • European Heart Network
        Diet, physical activity and cardiovascular disease prevention in Europe.
        2011
        • Keys A.
        Effects of different dietary fats on plasma-lipid levels.
        Lancet. 1965; 1: 318-319
        • Siri-Tarino P.W.
        • Sun Q.
        • Hu F.B.
        • Krauss R.M.
        Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease.
        Am J Clin Nutr. 2010; 91: 535-546
        • Stamler J.
        Diet–heart: a problematic revisit.
        Am J Clin Nutr. 2010; 91: 497-499
        • Mensink R.P.
        • Katan M.B.
        Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials.
        Arterioscler Thromb. 1992; 12: 911-919
        • He K.
        • Song Y.
        • Daviglus M.L.
        • Liu K.
        • Van Horn L.
        • Dyer A.R.
        • et al.
        Fish consumption and incidence of stroke: a meta-analysis of cohort studies.
        Stroke. 2004; 35: 1538-1542
        • Mozaffarian D.
        • Clarke R.
        Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils.
        Eur J Clin Nutr. 2009; 63: S22-S33
        • He F.J.
        • MacGregor G.A.
        Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health.
        J Hum Hypertens. 2002; 16: 761-770
        • Sacks F.M.
        • Svetkey L.P.
        • Vollmer W.M.
        • Appel L.J.
        • Bray G.A.
        • Harsha D.
        • et al.
        Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH–Sodium collaborative research group.
        N Engl J Med. 2001; 344: 3-10
        • Bibbins-Domingo K.
        • Chertow G.M.
        • Coxson P.G.
        • Moran A.
        • Lightwood J.M.
        • Pletcher M.J.
        • et al.
        Projected effect of dietary salt reductions on future cardiovascular disease.
        N Engl J Med. 2010; 362: 590-599
        • He F.J.
        • MacGregor G.A.
        Fortnightly review: beneficial effects of potassium.
        BMJ. 2001; 323: 497-501
        • Vivekananthan D.P.
        • Penn M.S.
        • Sapp S.K.
        • Hsu A.
        • Topol E.J.
        Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.
        Lancet. 2003; 361: 2017-2023
        • Humphrey L.L.
        • Fu R.
        • Rogers K.
        • Freeman M.
        • Helfand M.
        Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.
        Mayo Clin Proc. 2008; 83: 1203-1212
        • Marti-Carvajal A.J.
        • Sola I.
        • Lathyris D.
        • Salanti G.
        Homocysteine lowering interventions for preventing cardiovascular events.
        Cochrane Database Syst Rev. 2009; 4: CD006612
        • Armitage J.M.
        • Bowman L.
        • Clarke R.J.
        • Wallendszus K.
        • Bulbulia R.
        • Rahimi K.
        • et al.
        Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
        JAMA. 2010; 303: 2486-2494
        • Galan P.
        • Kesse-Guyot E.
        • Czernichow S.
        • Briancon S.
        • Blacher J.
        • Hercberg S.
        Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.
        BMJ. 2010; 341: c6273
      3. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebocontrolled trial.
        Lancet Neurol. 2010; 9: 855-865
        • Abuannadi M.
        • O’Keefe J.
        Give me sunshine: vitamin D cardiovascular health.
        Prim Care Cardiovasc J. 2011; 4: 59-62
        • Weickert M.O.
        • Pfeiffer A.F.
        Metabolic effects of dietary fiber consumption and prevention of diabetes.
        J Nutr. 2008; 138: 439-442
        • Food and Nutrition Board
        Dietary reference intakes for energy, carbohydrates, fiber, fat, fatty acids, cholesterol, protein and Amino acids.
        National Academies Press, Washington DC2002
        • Appel L.J.
        • Moore T.J.
        • Obarzanek E.
        • Vollmer W.M.
        • Svetkey L.P.
        • Sacks F.M.
        • et al.
        A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.
        N Engl J Med. 1997; 336: 1117-1124
        • Mozaffarian D.
        • Rimm E.B.
        Fish intake, contaminants, and human health: evaluating the risks and the benefits.
        JAMA. 2006; 296: 1885-1899
        • Opie L.H.
        • Lecour S.
        The red wine hypothesis: from concepts to protective signalling molecules.
        Eur Heart J. 2007; 28: 1683-1693
        • Malik V.S.
        • Popkin B.M.
        • Bray G.A.
        • Despres J.P.
        • Hu F.B.
        Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk.
        Circulation. 2010; 121: 1356-1364
        • Fung T.T.
        • Malik V.
        • Rexrode K.M.
        • Manson J.E.
        • Willett W.C.
        • Hu F.B.
        Sweetened beverage consumption and risk of coronary heart disease in women.
        Am J Clin Nutr. 2009; 89: 1037-1042
        • Law M.
        Plant sterol and stanol margarines and health.
        BMJ. 2000; 320: 861-864
        • Schonfeld G.
        Plant sterols in atherosclerosis prevention.
        Am J Clin Nutr. 2010; 92: 3-4
        • Verschuren W.M.
        • Jacobs D.R.
        • Bloemberg B.P.
        • Kromhout D.
        • Menotti A.
        • Aravanis C.
        • et al.
        Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study.
        JAMA. 1995; 274: 131-136
        • Talbot L.A.
        • Morrell C.H.
        • Fleg J.L.
        • Metter E.J.
        Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging.
        Prev Med. 2007; 45: 169-176
        • Nocon M.
        • Hiemann T.
        • Muller-Riemenschneider F.
        • Thalau F.
        • Roll S.
        • Willich S.N.
        Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis.
        Eur J Cardiovasc Prev Rehabil. 2008; 15: 239-246
        • Lollgen H.
        • Bockenhoff A.
        • Knapp G.
        Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories.
        Int J Sports Med. 2009; 30: 213-224
        • Schnohr P.
        • Scharling H.
        • Jensen J.S.
        Intensity versus duration of walking, impact on mortality: the Copenhagen City heart study.
        Eur J Cardiovasc Prev Rehabil. 2007; 14: 72-78
        • Taylor R.S.
        • Brown A.
        • Ebrahim S.
        • Jolliffe J.
        • Noorani H.
        • Rees K.
        • et al.
        Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.
        Am J Med. 2004; 116: 682-692
        • Piepoli M.F.
        • Davos C.
        • Francis D.P.
        • Coats A.J.
        Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).
        BMJ. 2004; 328: 189